Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04546074
Status:
RECRUITING
Last Update Posted:
2023-10-03
First Post:
2020-08-29
Brief Title:
Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma
Sponsor:
Organization:
Keio University